The Discounted Cash Flow (DCF) valuation of Eastwood Bio-Medical Canada Inc (EBM.V) is (0.11) CAD. With the latest stock price at 0.39 CAD, the upside of Eastwood Bio-Medical Canada Inc based on DCF is -127.9%.
Based on the latest price of 0.39 CAD and our DCF valuation, Eastwood Bio-Medical Canada Inc (EBM.V) is a sell. selling EBM.V stocks now will result in a potential gain of 127.9%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 5.7% - 7.4% | 6.5% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (0.37) - (0.07) | (0.11) |
| Upside | -196.7% - -116.9% | -127.9% |